Boston Scientific Defibrillator Wins Fda Nod
Source: Business Journal
Friday 19th March, 2010
has approved a new use for one of its defibrillator products. The FDA's Circulatory Systems Devices Panel has approved the use of Boston Scientific's (NYSE: BSX) cardiac resynchronization... ...
Read the full story at
Business Journal
Email this story to a friend
Have your say on this story
